At the same time, PFS and DFS also showed a trend of less benefit for patients with high expression of gastric cancer (Fig. 2 D).
← all excerpts
Expression of HECTD2 predicts peritoneal metastasis of gastric cancer and reconstructs immune microenvironment.
1
—
—